|Articles|September 1, 2001
- Applied Clinical Trials-09-01-2001
Randomized Controlled Trials
New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.
Advertisement
Articles in this issue
about 25 years ago
Connecting at the Connectathonabout 25 years ago
Patient Demands vs. Product Developmentabout 25 years ago
EU Proposes Authorization Changesabout 25 years ago
FDA Warning Lettersabout 25 years ago
The Clinical Audit in Pharmaceutical Developmentabout 25 years ago
What a Form 483 Really Meansabout 25 years ago
Effective Invvestigator Meetingsabout 25 years ago
A New Challange for Central Laboratoriesabout 25 years ago
Domenico Criscuoloabout 25 years ago
Monitoring Where Others Take HolidaysAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
2
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
3
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
4
Workforce Compression in AI-Driven Clinical Trial Operations
5